Modified T cells, pharmaceutical composition, manufacturing method thereof, and method of using the same
US11999968B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2021 |
| Grant date | Jun 4, 2024 |
| Priority date | — |
| Expiry date | Jan 20, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/2302
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides modified T cells possessing both cell killing function and antigen presenting cell function and method of culturing the same. By administration of the modified T cell, cancer cells in a subject may be effectively inhibited via cell-mediated immunity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.